Silymarin Decreases Connective Tissue Growth Factor to Improve Liver Fibrosis in Rats Treated with Carbon Tetrachloride

Phytotherapy Research

Volumn 27, Issue 7, 2013, Pages 1023-1028

  Tzeng, Jann Inn ^a,b   Chen, Mei Fen ^c   Chung, Hsien Hui ^d   Cheng, Juei Tang ^b,d,e  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

antifibrotic effect; carbon tetrachloride; hepatic fibrosis; silymarin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CONNECTIVE TISSUE GROWTH FACTOR; GLUTATHIONE PEROXIDASE; SILYMARIN; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; LIVER FIBROSIS; LIVER PROTECTION; MALE; NONHUMAN; RAT; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIFIBROTIC EFFECT; CARBON TETRACHLORIDE; HEPATIC FIBROSIS; SILYMARIN;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE; CONNECTIVE TISSUE GROWTH FACTOR; GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; LIVER CIRRHOSIS; MALE; RATS; RATS, WISTAR; SILYMARIN; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 84879927679     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4829     Document Type: Article

References (42)

1. Abe W, Ikejima K, Lang T, et al,. 2007. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. J Hepatol 46: 286-294.
2. Bai X, Qiu A, Guan J, Shi Z,. 2007. Antioxidant and protective effect of an oleanolic acid-enriched extract of A. deliciosa root on carbon tetrachloride induced rat liver injury. Asia Pac J Clin Nutr 16 (Suppl 1): 169-173.
3. Basu S,. 1999. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem Biophys Res Commun 254: 764-767.
4. Bisht S, Khan MA, Bekhit M, et al,. 2011. A polymeric nanoparticle formulation of curcumin (NanoCurc) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest 91: 1383-1395.
5. Bocchieri MH, Christner PJ, Henriksen PD, Jimenez SA,. 1993. Immunological characterization of (tight skin/NZB)F1 hybrid mice with connective tissue and autoimmune features resembling human systemic sclerosis. J Autoimmun 6: 337-351.
6. Chander R, Kapoor NK, Dhawan BN,. 1989. Hepatoprotective activity of silymarin against hepatic damage in Mastomys natalensis infected with Plasmodium berghei. Indian J Med Res 90: 472-477.
7. Chen L, Pan DD, Zhou J, Jiang YZ,. 2005. Protective effect of selenium-enriched Lactobacillus on CCl4-induced liver injury in mice and its possible mechanisms. World J Gastroenterol 11: 5795-5800.
8. Colgrave ML, Allingham PG, Tyrrell K, Jones A,. 2012. Multiple reaction monitoring for the accurate quantification of amino acids: using hydroxyproline to estimate collagen content. Methods Mol Biol 828: 291-303.
9. Diao Y, Zhao XF, Lin JS, Wang QZ, Xu RA,. 2011. Protection of the liver against CCl4-induced injury by intramuscular electrotransfer of a kallistatin-encoding plasmid. World J Gastroenterol 17: 111-117.
10. Feher J, Lengyel G,. 2012. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Curr Pharm Biotechnol 13: 210-217.
11. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, et al,. 2011. Inflammation, oxidative stress, and obesity. Int J Mol Sci 12: 3117-3132.
12. Fu Y, Zheng S, Lin J, Ryerse J, Chen A,. 2008. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73: 399-409.
13. Ha HL, Shin HJ, Feitelson MA, Yu DY,. 2010. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 16: 6035-6043.
14. Hamdy N, El-Demerdash E,. 2012. New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage. Toxicol Appl Pharmacol 261: 292-299.
15. Hannivoort RA, Hernandez-Gea V, Friedman SL,. 2012. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair 5: 1.
16. Hong RT, Xu JM, Mei Q,. 2009. Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol 15: 1452-1458.
17. Kim BM, Rhee JS, Park GS, Lee J, Lee YM, Lee JS,. 2011. Cu/Zn- and Mn-superoxide dismutase (SOD) from the copepod Tigriopus japonicus: molecular cloning and expression in response to environmental pollutants. Chemosphere 84: 1467-1475.
18. Kiruthiga PV, Pandian SK, Devi KP,. 2010. Silymarin protects PBMC against B(a)P induced toxicity by replenishing redox status and modulating glutathione metabolizing enzymes - an in vitro study. Toxicol Appl Pharmacol 247: 116-128.
19. Kobayashi H, Tanaka Y, Asagiri K, et al,. 2010. The antioxidant effect of green tea catechin ameliorates experimental liver injury. Phytomedicine 17: 197-202.
20. Lang I, Deak G, Muzes G, Pronai L, Feher J,. 1993. Effect of the natural bioflavonoid antioxidant silymarin on superoxide dismutase (SOD) activity and expression in vitro. Biotechnol Ther 4: 263-270.
21. Li C, Jiang W, Zhu H, Hou J,. 2012. Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis. Pharm Biol 50: 413-419.
22. Li G, Xie Q, Shi Y, et al,. 2006. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J Gene Med 8: 889-900.
23. Li W, Zhu C, Chen X, Li Y, Gao R, Wu Q,. 2011. Pokeweed antiviral protein down-regulates Wnt/beta-catenin signalling to attenuate liver fibrogenesis in vitro and in vivo. Dig Liver Dis 43: 559-566.
24. Lin HM, Tseng HC, Wang CJ, Lin JJ, Lo CW, Chou FP,. 2008. Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats. Chem Biol Interact 171: 283-293.
25. Luedde T, Schwabe RF,. 2011. NF-kappaB in the liver - linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 8: 108-118.
26. Maharshak N, Halfon P, Deutsch V, et al,. 2011. Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation. World J Gastroenterol 17: 5007-5013.
27. Muriel P, Mourelle M,. 1990. Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol 10: 275-279.
28. Naik SR, Panda VS,. 2007. Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride-induced liver injury in rodents. Liver Int 27: 393-399.
29. Ostergaard S, Holm A,. 1997. Synthesis and screening of an indexed motif-library containing non-proteinogenic amino acids. J Pept Sci 3: 123-132.
30. Parés A, Planas R, Torres M, et al,. 1998. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol 28: 615-621.
31. Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S,. 2011. Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage. Arch Pharm Res 34: 767-774.
32. Ping J, Gao AM, Qin HQ, et al,. 2011. Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of kappaB kinase alpha/inhibitor of kappaB-alpha/nuclear factor-kappaB pathway. J Pharmacol Exp Ther 339: 694-703.
33. Prakobwong S, Charoensuk L, Hiraku Y, et al,. 2011. Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma. Int J Cancer. DOI: 10.1002/ijc.26443.
34. Shahjahan M, Vani G, Devi CS,. 2005. Protective effect of Indigofera oblongifolia in CCl4-induced hepatotoxicity. J Med Food 8: 261-265.
35. Shaker E, Mahmoud H, Mnaa S,. 2010. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food Chem Toxicol 48: 803-806.
36. Shih CC, Wu YW, Lin WC,. 2005. Aqueous extract of Anoectochilus formosanus attenuate hepatic fibrosis induced by carbon tetrachloride in rats. Phytomedicine 12: 453-460.
37. Starr SP, Raines D,. 2011. Cirrhosis: diagnosis, management, and prevention. Am Fam Physician 84: 1353-1359.
38. Tirkey N, Pilkhwal S, Kuhad A, Chopra K,. 2005. Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol 5: 2.
39. Tsai JH, Liu JY, Wu TT, et al,. 2008. Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats. J Viral Hepat 15: 508-514.
40. Tu CT, Guo JS, Wang M, Wang JY,. 2007. Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury. J Gastroenterol Hepatol 22: 877-884.
41. Wang T, Zhao LJ, Li P, et al,. 2011. Hepatoprotective effects and mechanisms of dehydrocavidine in rats with carbon tetrachloride-induced hepatic fibrosis. J Ethnopharmacol 138: 76-84
42. Yang H, Zhao LF, Zhao ZF, Wang Y, Zhao JJ, Zhang L,. 2012. Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARgamma and NF-kappaB. World J Gastroenterol 18: 1680-1688.